Samsung Biologics Co Ltd (207940) Earnings Date
Samsung Biologics Co Ltd (207940) reports Q4 2026 earnings on Wednesday, January 20, 2027, before the market opens. Analysts expect earnings per share of 10,195.26. Its last report (Q3 2026) came on November 16, 2026: EPS of 8,458.00 against 9,799.29 expected, a 13.7% miss.
Updated Source: MacroFinance earnings databaseRefreshed every 15 minutes
- Date
- Wed, Jan 20, 2027
- Time
- Before the market opens
- Quarter
- Q4 2026
- EPS estimate
- 10,195.26
- EPS a year ago
- n/a
- Revenue estimate
- n/a
- Revenue a year ago
- n/a
Samsung Biologics Co Ltd earnings history
Every report we track, newest first. EPS and revenue are in the currency the company reports in.
| Date | Quarter | Time | EPSEstimate | EPSActual | EPSSurprise | EPSYear ago | RevenueEstimate | RevenueActual |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2027 | Q4 2026 | BMO | 10,195.26 | — | — | — | — | — |
| Nov 16, 2026 | Q3 2026 | BMO | 9,799.29 | 8,458.00 | −13.7% | — | — | — |
| Oct 27, 2026 | Q3 2026 | BMO | 9,799.29 | 8,458.00 | −13.7% | — | — | — |
| Aug 14, 2026 | Q2 2026 | BMO | 9,873.54 | 9,314.00 | −5.7% | — | — | — |
| May 15, 2026 | Q1 2026 | BMO | 9,544.89 | 10,148.00 | +6.3% | — | — | — |
| Feb 25, 2026 | Q4 2025 | BMO | 11,382.97 | 8,723.00 | −23.4% | — | — | — |
| Nov 14, 2025 | Q3 2025 | BMO | 10,335.52 | 8,071.00 | −21.9% | — | — | — |
| Aug 14, 2025 | Q2 2025 | BMO | 7,073.89 | 7,008.09 | −0.9% | — | — | — |
Also reporting on Wednesday, January 20
A free account adds Samsung Biologics Co Ltd to your watchlist, so its earnings dates are highlighted on every calendar and the stock shows up in your Flow and daily briefing.
Put this on your site
Free widget for blogs, newsletters and broker sites. It updates on its own and links back here.
<iframe src="https://macrofinance.ai/earnings-calendar/embed/?view=ticker&t=207940-kr" width="100%" height="380" style="border:0" loading="lazy" title="Earnings calendar by MacroFinance"></iframe> <p style="font-size:12px"><a href="https://macrofinance.ai/earnings/207940-kr/">Earnings date</a> by MacroFinance</p>
Samsung Biologics Co Ltd earnings FAQ
When does Samsung Biologics Co Ltd report earnings?
Samsung Biologics Co Ltd reports Q4 2026 results on Wednesday, January 20, 2027, before the market opens.
What EPS do analysts expect from Samsung Biologics Co Ltd?
The consensus is 10,195.26 per share. Figures are in the currency the company reports in.
Did Samsung Biologics Co Ltd beat earnings estimates last quarter?
No. On November 16, 2026 it reported EPS of 8,458.00 against 9,799.29 expected (−13.7%). It beat in 1 of the last 7 quarters we track.
What do BMO and AMC mean?
BMO (before market open) means results come out before trading starts on the home exchange; AMC (after market close) means after trading ends. Earnings often move the stock at the next open.